Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)		Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated other Comprehensive Income (Loss)	Total
Balance at Dec. 31, 2022		$ 130	$ 50,198,630	$ (45,099,116)	$ 22,006	$ 5,121,650
Balance (in Shares) at Dec. 31, 2022		1,302,113
Exercise of warrants		$ 186	1,674			1,860
Exercise of warrants (in Shares)		1,860,000
Stock-based compensation			10,630			10,630
Common stock and warrants issued in private placement, net of offering costs		$ 14	8,909,516			8,909,530
Common stock and warrants issued in private placement, net of offering costs (in Shares)		140,000
Cumulative translation adjustment					5,370	5,370
Net loss				(2,183,507)		(2,183,507)
Balance at Mar. 31, 2023		$ 330	59,120,450	(47,282,623)	27,376	11,865,533
Balance (in Shares) at Mar. 31, 2023		3,302,113
Balance at Dec. 31, 2022		$ 130	50,198,630	(45,099,116)	22,006	5,121,650
Balance (in Shares) at Dec. 31, 2022		1,302,113
Net loss						(4,056,538)
Balance at Jun. 30, 2023		$ 330	59,130,198	(49,155,654)	(23,712)	9,951,162
Balance (in Shares) at Jun. 30, 2023		3,302,113
Balance at Mar. 31, 2023		$ 330	59,120,450	(47,282,623)	27,376	11,865,533
Balance (in Shares) at Mar. 31, 2023		3,302,113
Stock-based compensation			9,748			9,748
Cumulative translation adjustment					(51,088)	(51,088)
Net loss				(1,873,031)		(1,873,031)
Balance at Jun. 30, 2023		$ 330	59,130,198	(49,155,654)	(23,712)	9,951,162
Balance (in Shares) at Jun. 30, 2023		3,302,113
Balance at Dec. 31, 2023		$ 435	61,732,106	(52,944,506)	27,260	8,815,295
Balance (in Shares) at Dec. 31, 2023		4,348,129
Exercise of pre-funded warrants		$ 5	(5)
Exercise of pre-funded warrants (in Shares)		55,675
Stock-based compensation			513,350			513,350
Deferred offering cost related to warrant inducement			550,500			550,500
Cumulative translation adjustment					(5,768)	(5,768)
Net loss				(2,040,783)		(2,040,783)
Balance at Mar. 31, 2024		$ 440	62,795,951	(54,985,289)	21,492	7,832,594
Balance (in Shares) at Mar. 31, 2024		4,403,804
Balance at Dec. 31, 2023		$ 435	61,732,106	(52,944,506)	27,260	8,815,295
Balance (in Shares) at Dec. 31, 2023		4,348,129
Net loss						(3,673,257)
Balance at Jun. 30, 2024		$ 536	65,934,709	(56,617,763)	23,126	9,340,608
Balance (in Shares) at Jun. 30, 2024		5,358,804
Balance at Mar. 31, 2024		$ 440	62,795,951	(54,985,289)	21,492	7,832,594
Balance (in Shares) at Mar. 31, 2024		4,403,804
Exercise of pre-funded warrants
Common shares issued and issuable for exercise of warrants	[1]	$ 96	3,682,204			3,682,300
Common shares issued and issuable for exercise of warrants (in Shares)	[1]	955,000
Stock-based compensation			7,054			7,054
Deferred offering cost related to warrant inducement			(550,500)			(550,500)
Cumulative translation adjustment					1,634	1,634
Net loss				(1,632,474)		(1,632,474)
Balance at Jun. 30, 2024		$ 536	$ 65,934,709	$ (56,617,763)	$ 23,126	$ 9,340,608
Balance (in Shares) at Jun. 30, 2024		5,358,804

[1] Represents the aggregate fair value of 2,500,000 shares of common stock, which includes 955,000 shares that have been issued and 1,545,000 shares held in abeyance (See Note 5 – Stockholders’ Equity – Warrants for additional information.